ERISA Ledger · U.S. DOL EBSA Form 5500 (2023)

Oyster Point Pharma, INC.

Official 2023 U.S. DOL Form 5500 summary for Oyster Point Pharma, INC. (Oyster Point Pharma, INC. 401(k) Plan · EIN 81-1030955 · PN 001): $16.93M net assets, 240 active participants, and $79.80 per $10,000 (79.80 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorOyster Point Pharma, INC.
Filing IdentifierOyster Point Pharma, INC. 401(k) Plan · EIN 81-1030955 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2023)$16.93M
Active Participants240
Direct Admin Fee Rate$79.80 per $10,000 (79.80 bps)
Cohort Peer Median$34.74 per $10,000 (34.74 bps)
Primary Recordkeeper / ProviderT. Rowe Price
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI